Michael Adasczik
Principal Accounting Officer, Sio Gene Therapies Inc.
Companies
- B&G FoodsVP, Chief Accounting Officer Nov 16, 2018 to now1
- Sio Gene Therapies Inc.Principal Accounting Officer Aug 18, 2015 to May 2, 20172
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 25, 2026Shares withheld for tax 2,625 shares at $5.11 of B&G Foods3
- Mar 25, 2026Granted 14,991 shares of B&G Foods3
- Mar 2, 2026Shares withheld for tax 5,289 shares at $5.18 of B&G Foods4
- Mar 2, 2026Granted 13,185 shares of B&G Foods4
- Mar 25, 2025Shares withheld for tax 1,403 shares at $6.60 of B&G Foods5
- Mar 25, 2025Granted 11,119 shares of B&G Foods5
- Mar 25, 2024Shares withheld for tax 696 shares at $11.36 of B&G Foods6
- Mar 25, 2024Granted 6,879 shares of B&G Foods6
- Mar 25, 2023Shares withheld for tax 250 shares at $15.16 of B&G Foods7
- Mar 24, 2023Granted 4,991 shares of B&G Foods7
- Feb 27, 2023Shares withheld for tax 2,486 shares at $12.60 of B&G Foods8
- Feb 27, 2023Granted 6,276 shares of B&G Foods8
- Mar 25, 2022Granted 583 shares of B&G Foods9
- Mar 25, 2022Shares withheld for tax 180 shares at $27.34 of B&G Foods9
- Feb 28, 2022Shares withheld for tax 1,883 shares at $29.60 of B&G Foods10
- Feb 28, 2022Granted 5,014 shares of B&G Foods10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Mar 4, 2026
- 5SEC EDGARForm 4 filed Mar 27, 2025
- 6SEC EDGARForm 4 filed Mar 27, 2024
- 7SEC EDGARForm 4 filed Mar 28, 2023
- 8SEC EDGARForm 4 filed Mar 1, 2023
- 9SEC EDGARForm 4 filed Mar 29, 2022
- 10SEC EDGARForm 4 filed Mar 2, 2022